News

Filter

Current filters:

None

82 to 91 of 96142 results

Positive new data on Boehringer’s nintedanib in IPF patients

10-09-2014

A pre-specified subgroup analysis from the two replicate Phase III INPULSI trials, presented today at…

Boehringer IngelheimnintedanibPharmaceuticalResearchRespiratory and Pulmonary

ReproCELL acquires the iPS Cell Business unit of Stemgent

10-09-2014

Japan-based ReproCELL is to acquire the iPS Cell Business unit of Privately-held US firm Stemgent. This…

BiotechnologyMergers & AcquisitionsReproCELLStemgent

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

10-09-2014

Ireland-based generic drug major Actavis yesterday confirmed that the US Food and Drug Administration's…

ActavisCardio-vascularnebivololPharmaceuticalRegulationUSAvalsartan

Oliver Siegel appointed chief operating officer at AFFiRiS

Oliver Siegel appointed chief operating officer at AFFiRiS

09-09-2014

Oliver Siegel has been appointed as chief operating officer at Austrian vaccine specialist AFFiRiS AG,…

AFFiRiSAustriaBoardroomChronic diseasesOliver SiegelPharmaceuticalVaccine specialist

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

09-09-2014

UK pharma giant GlaxoSmithKline today announced a £5 million ($8.2 million) collaboration with the UK…

FinancialGlaxoSmithKlinePharmaceuticalResearchSouth AfricaUK

82 to 91 of 96142 results

Back to top